Rostislav Raykov is the founder of Fennec Pharmaceuticals. Backed by Southpoint Capital Advisors LP, Alfasigma S.p.A..
Rostislav Raykov served as the CEO of Fennec Pharmaceuticals, a biopharmaceutical company, and was a member of its Board of Directors until his retirement. Fennec Pharmaceuticals focuses on its product candidate PEDMARK for preventing platinum-induced ototoxicity in pediatric patients.
Full founder directory · Investor directory · Company funding database · Fundraising library